Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-20

FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Ketorolac tromethamine as an Original Application generic for Camber Pharmaceuticals, Inc., adding a new generic entry to the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)